Michael F. Roman - 31 Mar 2025 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Role
Director
Signature
/s/ Michael F. Roman by Jessica H. Paik, Attorney-in-Fact
Issuer symbol
ABT
Transactions as of
31 Mar 2025
Transactions value $
$35,152
Form type
4
Filing time
02 Apr 2025, 17:30:06 UTC
Previous filing
18 Feb 2025
Next filing
29 Apr 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABT Stock Equivalent Units Award $35.2K +265 +5.65% $132.65 4.96K 31 Mar 2025 Common Shares 265 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.
F2 Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.